Universal Vision Biotechnology Co., Ltd. (TPEX:3218)

TPEX:3218 Revenue

In the year 2024, Universal Vision Biotechnology had annual revenue of 4.23B TWD with 3.58% growth. Universal Vision Biotechnology had revenue of 1.04B in the quarter ending December 31, 2024, with 4.56% growth.

• Revenue: 4.23B
• Revenue Growth: +3.58%
• P/S Ratio: 4.10
• Revenue / Employee: 10.54M
• Employees: 401
• Market Cap: 17.33B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	4.23B	146.05M	3.58%
Dec 31, 2023	4.08B	588.20M	16.83%
Dec 31, 2022	3.49B	862.26M	32.76%
Dec 31, 2021	2.63B	578.66M	28.18%
Dec 31, 2020	2.05B	634.16M	44.69%